Rob is an experienced C-level executive with 25 years in building technology focused businesses in the healthcare space. Rob has founded and transitioned several start-up companies most recently as CEO of clinical-stage QUE Oncology and as the inaugural CEO of ASX-listed cancer drug company Prescient Therapeutics. As former Head of Melbourne Operations for Arana Therapeutics, Rob played a key role in Arana’s successful A$318M acquisition by Cephalon Incorporated. Rob provides specialist advice to companies looking to turn smart innovation into commercial ventures.
Written by The Marketing Co, Instructor
Share this article: